Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Q4 2024 value amounting to $540000.0.
- Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization rose 344.83% to $540000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $540000.0, marking a year-over-year increase of 344.83%. This contributed to the annual value of $540000.0 for FY2024, which is 344.83% up from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Accumulated Depreciation & Amortization stood at $540000.0 for Q4 2024, which was up 344.83% from $522000.0 recorded in Q4 2023.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization ranged from a high of $540000.0 in Q4 2024 and a low of $25000.0 during Q2 2021
- Its 5-year average for Accumulated Depreciation & Amortization is $181636.4, with a median of $68000.0 in 2020.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first tumbled by 6093.75% in 2021, then skyrocketed by 15000.0% in 2022.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization stood at $239000.0 in 2020, then plummeted by 49.79% to $120000.0 in 2021, then surged by 150.0% to $300000.0 in 2022, then skyrocketed by 74.0% to $522000.0 in 2023, then rose by 3.45% to $540000.0 in 2024.
- Its last three reported values are $540000.0 in Q4 2024, $522000.0 for Q4 2023, and $300000.0 during Q4 2022.